Skip to main content

CORRECTION article

Front. Genet., 21 June 2019
Sec. Pharmacogenetics and Pharmacogenomics
This article is part of the Research Topic Epigenetic Approaches in Drug Discovery, Development and Treatment View all 10 articles

Corrigendum: Using Integrative Analysis of DNA Methylation and Gene Expression Data in Multiple Tissue Types to Prioritize Candidate Genes for Drug Development in Obesity

\nQingjie Guo,Qingjie Guo1,2Ruonan ZhengRuonan Zheng3Jiarui HuangJiarui Huang3Meng HeMeng He3Yuhan WangYuhan Wang3Zonghao GuoZonghao Guo3Liankun Sun
&#x;Liankun Sun4*Peng Chen,
&#x;Peng Chen1,2*
  • 1Department of Genetics, College of Basic Medical Sciences, Jilin University, Changchun, China
  • 2Key Laboratory of Pathobiology, Ministry of Education, Jilin University, Changchun, China
  • 3College of Clinical Medicine, Jilin University, Changchun, China
  • 4Department of Pathophysiology, College of Basic Medical Sciences, Jilin University, Changchun, China

A Corrigendum on
Using Integrative Analysis of DNA Methylation and Gene Expression Data in Multiple Tissue Types to Prioritize Candidate Genes for Drug Development in Obesity

by Guo, Q., Zheng, R., Huang, J., He, M., Wang, Y., Guo, Z., et al. (2018). Front. Genet. 9:663. doi: 10.3389/fgene.2018.00663

In the published article, there was an error regarding the affiliation for Liankun Sun. He should have the affiliation 4Department of Pathophysiology, College of Basic Medical Sciences, Jilin University, Changchun, China instead of the affiliation 1Department of Genetics, College of Basic Medical Sciences, Jilin University, Changchun, China.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: DNA methylation, obesity, association, gene expression, CpG

Citation: Guo Q, Zheng R, Huang J, He M, Wang Y, Guo Z, Sun L and Chen P (2019) Corrigendum: Using Integrative Analysis of DNA Methylation and Gene Expression Data in Multiple Tissue Types to Prioritize Candidate Genes for Drug Development in Obesity. Front. Genet. 10:571. doi: 10.3389/fgene.2019.00571

Received: 06 May 2019; Accepted: 31 May 2019;
Published: 21 June 2019.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2019 Guo, Zheng, Huang, He, Wang, Guo, Sun and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Peng Chen, pchen@jlu.edu.cn; Liankun Sun, sunlk@jiu.edu.cn

These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.